iPSC-hDPSC

Unit

3 x 10^6 cells/ml

Cell Type

Immortalized Cells

Tissue Type

iPSC

Organism

Human

Donor History

Normal donor

Growth Properties

Adherent

Growth Conditions

Culture medium: mTESR. Dissociation reagent: ReLeSR. Seeding density: To ensure optimal cell growth and experimental consistency

,

it is recommended to use a seeding density of 5

,

000 to 10

,

000 cells/cm² once the cells have adapted to the culture conditions. Freeze medium: As a cryopreservation medium

,

we use 80% FBS + 10% basal medium + 10% DMSO to maintain viability

,

or CM-1 (Cytion catalog number 800100) for superior cryoprotection

,

preventing unwanted differentiation while preserving pluripotency and cellular integrity. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/iPSC-hDPSC/300622

SKU: 300622 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

The iPSC-hDPSC cell line represents a cutting-edge model derived from human dental pulp stem cells (hDPSCs). These cells originate from dental pulp tissue, where they undergo enzymatic digestion to isolate the adherent fraction. Upon reaching 70-80% confluence, the cells are subcultured and cryopreserved at Passage 1. This foundational step is crucial in maintaining the cellular integrity and ensuring the viability of the stem cells for future applications.

The reprogramming of hDPSCs into induced pluripotent stem cells (iPSCs) is a significant advancement, achieved through an episomal reprogramming technique. This method employs vectors that incorporate the Yamanaka factors-Oct-4, Sox-2, and Klf-4-alongside p53 Anti-sense, EBNA-1, and a Red Fluorescent Protein marker. The episomal approach is particularly advantageous as it avoids the integration of reprogramming factors into the genome, thus preserving the genetic stability of the iPSCs. The resultant iPSC-hDPSC line exhibits pluripotent characteristics, making it a valuable tool for research in regenerative medicine, disease modeling, and drug discovery.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.